Nefazodone and Palbociclib: Interaction Details

Brand names
Nefazodone
Serzone
Palbociclib
Ibrance
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

What Happens When You Take Nefazodone With Palbociclib

What can happen when they are taken together (rated Major)

Increased palbociclib exposure

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Palbociclib is a , so using it together with strong CYP3A should be avoided because palbociclib exposure may rise. In a study of palbociclib given with itraconazole, a strong CYP3A , palbociclib increased by 87% and by 34%.

Where possible, choose comedications that cause no or only minimal CYP3A . If a strong CYP3A inhibitor cannot be avoided, lower the palbociclib dose to 75 mg once daily for as long as the inhibitor is continued. Once 3 to 5 half-lives of the inhibitor have passed after it is stopped, return palbociclib to the dose that was used before the strong CYP3A inhibitor was started.1

The Nefazodone and Palbociclib Interaction, Explained

Nefazodone (an antidepressant) can slow down the liver enzyme () that breaks down palbociclib (Ibrance, a breast cancer medicine). This could cause more palbociclib to stay in your body, which may raise the chance of side effects such as low blood cell counts, infections, tiredness, or mouth sores. This concern is based on how the drugs work and on a similar drug, not on a study of nefazodone itself.

Please don't change or stop either medicine on your own. Talk with your pharmacist or doctor, who can review your options, adjust your palbociclib dose, and watch you more closely if both are needed.

Mechanism: Nefazodone is a strong ; palbociclib is a CYP3A . of CYP3A-mediated is expected to increase palbociclib exposure.

  • Magnitude: With itraconazole (strong CYP3A inhibitor), palbociclib rose 87% and 34%. No nefazodone-specific data are cited.
  • Onset: Unspecified.
  • Evidence: Theoretical (extrapolated from class effect); severity rated major.
  • Management: Avoid if possible and consider an alternative with minimal CYP3A inhibition. If is necessary, reduce palbociclib to 75 mg once daily. After 3 to 5 half-lives of the inhibitor since discontinuation, return to the prior dose. Monitor for and other palbociclib adverse effects.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Nefazodone and Palbociclib Interact

The likely mechanism

of -mediated palbociclib

In short: Nefazodone slows CYP3A, an enzyme that breaks down palbociclib, so palbociclib can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Nefazodone and Palbociclib Interaction

Your care team will usually try to avoid this pairing by choosing an antidepressant that has little effect on the enzyme. If both are needed, the palbociclib dose may be lowered (the documented adjustment is 75 mg once daily) while you take nefazodone, and your team may monitor you more closely.

  • Keep taking both medicines as prescribed until your prescriber advises otherwise.
  • Tell your pharmacist and doctor about all your medicines, including any you start or stop.
  • If nefazodone is stopped, the palbociclib dose may be raised back to your previous dose after several days (3 to 5 half-lives of nefazodone). Your team will guide the timing.
  • Report new infections, fever, unusual tiredness, or mouth sores promptly.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Nefazodone or Palbociclib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: IBRANCE oral capsules, palbociclib oral capsules

    In 12 healthy subjects, co-administration of a single 125 mg dose of palbociclib with itraconazole, a strong given as multiple doses of 200 mg/day, raised palbociclib by 87% and by 34% relative to palbociclib given alone.1

Nefazodone and Palbociclib: Common Questions

How serious is the Nefazodone and Palbociclib interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Nefazodone and Palbociclib interaction managed?

Your care team will usually try to avoid this pairing by choosing an antidepressant that has little effect on the enzyme. If both are needed, the palbociclib dose may be lowered (the documented adjustment is 75 mg once daily) while you take nefazodone, and your team may monitor you more closely. Keep taking both medicines as prescribed until your prescriber advises otherwise. Tell your pharm… Management is individual — always follow your own care team's guidance.

Does taking Nefazodone and Palbociclib at different times of day help?

No. Taking them at different times of day does not prevent this one. Nefazodone slows , an enzyme that breaks down palbociclib, so palbociclib can build up in the body. That change lasts while nefazodone is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

Is there an alternative to taking Nefazodone with Palbociclib?

The interaction record says a different medicine may be considered in place of one of these two.

Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Nefazodone and Palbociclib Interaction

Ask in your own words about taking Nefazodone and Palbociclib together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: IBRANCE(R) oral capsules, palbociclib oral capsules. Pfizer Labs (per FDA), New York, NY, 2016. DailyMed
Was this write-up helpful?

Other Serious Interactions of Nefazodone and Palbociclib

Also serious with Nefazodone

Also serious with Palbociclib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Nefazodone

With Palbociclib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.